|
1
|
Nistor R: Pituitary tumors. Neuro Rew.
57:264–272. 1996.
|
|
2
|
Kovacs K, Scheithauer BW, Horvath E and
Lloyd RV: The world health organization classification of
adenohypophysial neoplasms: A proposed five-tier scheme. Cancer.
78:502–510. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Monteiro ML, Moura FC and Cunha LP:
Frequency doubling perimetry in patients with mild and moderate
pituitary tumor-associated visual field defects detected by
conventional perimetry. Arq Bras Oftalmol. 70:323–329. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jagannathan J, Dumont AS, Prevedello DM,
Lopes B, Oskouian RJ, Jane JA Jr and Laws ER Jr: Genetics of
pituitary adenomas: Current theories and future implications.
Neurosurg Focus. 19:E42005.PubMed/NCBI
|
|
5
|
Yadav L, Puri N, Rastogi V, Satpute P,
Ahmad R and Kaur G: Matrix metalloproteinases and cancer-roles in
threat and therapy. Asian Pac J Cancer Prev. 15:1085–1091. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nam DH and Ge X: Direct production of
functional matrix metalloproteinase-14 without refolding or
activation and its application for in vitro inhibition assays.
Biotechnol Bioeng. 113:717–723. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lehti K, Allen E, Birkedal-Hansen H,
Holmbeck K, Miyake Y, Chun TH and Weiss SJ: An MT1-MMP-PDGF
receptor-beta axis regulates mural cell investment of the
microvasculature. Genes Dev. 19:979–991. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sabeh F, Ota I, Holmbeck K,
Birkedal-Hansen H, Soloway P, Balbin M, Lopez-Otin C, Shapiro S,
Inada M, Krane S, et al: Tumor cell traffic through the
extracellular matrix is controlled by the membrane-anchored
collagenase MT1-MMP. J Cell Biol. 167:769–781. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jiang WG, Davies G, Martin TA, Parr C,
Watkins G, Mason MD and Mansel RE: Expression of membrane type-1
matrix metalloproteinase, MT1-MMP in human breast cancer and its
impact on invasiveness of breast cancer cells. Int J Mol Med.
17:583–590. 2006.PubMed/NCBI
|
|
10
|
Massagué J: TGFbeta in Cancer. Cell.
134:215–230. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wakefield LM and Roberts AB: TGF-beta
signaling: Positive and negative effects on tumorigenesis. Curr
Opin Genet Dev. 12:22–29. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Johnson MD, Shaw AK, O'Connell MJ, Sim FJ
and Moses HL: Analysis of transforming growth factor beta receptor
expression and signaling in higher grade meningiomas. J Neurooncol.
103:277–285. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bruna A, Darken RS, Rojo F, Ocaña A,
Peñuelas S, Arias A, Paris R, Tortosa A, Mora J, Baselga J and
Seoane J: High TGFbeta-Smad activity confers poor prognosis in
glioma patients and promotes cell proliferation depending on the
methylation of the PDGF-B gene. Cancer Cell. 11:147–160. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu Y, Li Q, Zhou X, Yu J, Mu Y, Munker S,
Xu C, Shen Z, Müllenbach R, Liu Y, et al: Decreased levels of
active SMAD2 correlate with poor prognosis in gastric cancer. PLoS
One. 7:e356842012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Recouvreux MV, Lapyckyj L, Camilletti MA,
Guida MC, Ornstein A, Rifkin DB, Becu-Villalobos D and Díaz-Torga
G: Sex differences in the pituitary transforming growth factor-β1
system: Studies in a model of resistant prolactinomas.
Endocrinology. 154:4192–4205. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wilson CB: Neurosurgical management of
large and invasive pituitary tumors. Clinical Management of
Pituitary Disorders. Tindall GT and Collins WF: New York Raven
Press. (New York). 335–342. 1979.
|
|
17
|
Knosp E, Steiner E, Kitz K and Matula C:
Pituitary adenomas with invasion of the cavernous sinus space: A
magnetic resonance imaging classification compared with surgical
findings. Neurosurgery. 33:610–617; discussion 617–618. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li LC and Dahiya R: MethPrimer: Designing
primers for methylation PCRs. Bioinformatics. 18:1427–1431. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Page RB: Sellar and parasellar tumors.
Neurosurgery. Wilkins RH and Rengachary SS: McGraw-Hill. 791–804.
1996.
|
|
20
|
Heaney A: Management of aggressive
pituitary adenomas and pituitary carcinomas. J Neurooncol.
117:459–468. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kulis M and Esteller M: DNA methylation
and cancer. Adv Genet. 70:27–56. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chernov AV, Sounni NE, Remacle AG and
Strongin AY: Epigenetic control of the invasion-promoting
MT1-MMP/MMP-2/TIMP-2 axis in cancer cells. J Biol Chem.
284:12727–12734. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Altaş M, Bayrak OF, Ayan E, Bolukbasi F,
Silav G, Coskun KK, Culha M, Sahin F, Sevli S and Elmaci I: The
effect of polymorphisms in the promoter region of the MMP-1 gene on
the occurrence and invasiveness of hypophyseal adenoma. Acta
Neurochir (Wien). 152:1611–1617; discussion 1617. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hui P, Xu X, Xu L, Hui G, Wu S and Lan Q:
Expression of MMP14 in invasive pituitary adenomas: Relationship to
invasion and angiogenesis. Int J Clin Exp Pathol. 8:3556–3567.
2015.PubMed/NCBI
|
|
25
|
Recouvreux MV, Camilletti MA, Rifkin DB,
Becu-Villalobos D and Díaz-Torga G: Thrombospondin-1 (TSP-1)
analogs ABT-510 and ABT-898 inhibit prolactinoma growth and recover
active pituitary transforming growth factor-β1 (TGF-β1).
Endocrinology. 153:3861–3871. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhenye L, Chuzhong L, Youtu W, Xiaolei L,
Lei C, Lichuan H, Hongyun W, Yonggang W, Fei W and Yazhuo Z: The
expression of TGF-β1, Smad3, phospho-Smad3 and Smad7 is correlated
with the development and invasion of nonfunctioning pituitary
adenomas. J Transl Med. 12:712014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Elenkova A, Atanassova I, Kirilov G,
Vasilev V, Kalinov K and Zacharieva S: Transforming growth factor
β1 is not a reliable biomarker for valvular fibrosis but could be a
potential serum marker for invasiveness of prolactinomas (pilot
study). Eur J Endocrinol. 169:299–306. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen C, Zhao KN, Masci PP, Lakhani SR,
Antonsson A, Simpson PT and Vitetta L: TGFβ isoforms and receptors
mRNA expression in breast tumors: Prognostic value and clinical
implications. BMC Cancer. 15:10102015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu ZY, Zhang GL, Wang MM, Xiong YN and
Cui HQ: MicroRNA-663 targets TGFB1 and regulates lung cancer
proliferation. Asian Pac J Cancer Prev. 12:2819–2823.
2011.PubMed/NCBI
|
|
30
|
Wang Y, Jiang M, Li Z, Wang J, Du C,
Yanyang L, Yu Y, Wang X, Zhang N, Zhao M, et al: Hypoxia and TGF-β1
lead to endostatin resistance by cooperatively increasing cancer
stem cells in A549 transplantation tumors. Cell Biosci. 5:722015.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xiao Y, Yuan X, Qiu H and Li Q:
Single-nucleotide polymorphisms of TGFβ1 and ATM associated with
radiation-induced pneumonitis: A prospective cohort study of
thoracic cancer patients in China. Int J Clin Exp Med.
8:16403–16413. 2015.PubMed/NCBI
|
|
32
|
Sathyamoorthy T, Tezera LB, Walker NF,
Brilha S, Saraiva L, Mauri FA, Wilkinson RJ, Friedland JS and
Elkington PT: Membrane type 1 matrix metalloproteinase regulates
monocyte migration and collagen destruction in tuberculosis. J
Immunol. 195:882–891. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Johnson JL, Jenkins NP, Huang WC, Di
Gregoli K, Sala-Newby GB, Scholtes VP, Moll FL, Pasterkamp G and
Newby AC: Relationship of MMP-14 and TIMP-3 expression with
macrophage activation and human atherosclerotic plaque
vulnerability. Mediators Inflamm. 2014:2764572014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Vincze C, Pál G, Wappler EA, Szabó ER,
Nagy ZG, Lovas G and Dobolyi A: Distribution of mRNAs encoding
transforming growth factors-beta1, −2 and −3 in the intact rat
brain and after experimentally induced focal ischemia. J Comp
Neurol. 518:3752–3770. 2010. View Article : Google Scholar : PubMed/NCBI
|
